OPKO Announces Third Quarter 2013 Financial and Operating Highlights

13-11-2013 Business Wire HealthComments (0)

OPKO HealthPharmaceutical

OPKO Health, Inc. (NYSE:OPK), a multi-national biopharmaceutical and diagnostics company, today reported operating and financial highlights for the third quarter of 2013. Third Quarter 2013 Financial Highlights Cash, cash equivalents and marketable securities were $180.8 million as of September 30, 2013. Consolidated revenues nearly doubled to $20.6 million during the three months ended September 30, 2013 from $11.8 million in the prior year period. Consolidated revenue

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top